BUZZ-Valeant shares slide ahead of long-awaited earnings report

Mon Mar 14, 2016 10:46am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** U.S.-listed shares of Valeant Pharmaceuticals down 3.6 pct in Monday morning trading, ahead of expected Q4 earnings report on Tuesday

** Valeant shares worst daily perfomer in NYSE Arca Pharmaceutical index, which is off 0.7 pct

** Drugmaker is under pressure to introduce more transparency into operations, expand management ranks to regain credibility in the investment community, Reuters reported on Friday

** Shares have lost about three quarters of value from 52-week high of $263.81 reached in August, as it faced growing scrutiny over drug pricing and its connection to a specialty pharmacy

** YTD, Valeant shares are off 34 pct vs 6.5 pct decline for NYSE Arca pharma index